Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-05-27 19:25 CEST (UTC+2h)
helena colom

2017-02-02 21:51

Posting: # 17003
Views: 698

 Double peak in hydroxychloroquine plasma curves [Dissolution / BCS / IVIVC]

Dear all,
I have some double peak concentrations in almost all plasma concentration vs time curves of hydroxichloroquine sulfate (BCS class III drug) both for a test and a reference products (IR formulations). A large variability has been previously described for this drug in the literature, but nothing can be found about double peak concentrations.

I wonder if it could be due to an absorption window. The only think I was able to found is that the logP value is about 3.85, logD values change from 0.66 (pH=7.4) to -3.67 (pH=5.2) and the Pkas of the drug are 9.67 and 8.27.

Then, I wonder if as the pH increases along the GI tract, higher absorption takes place due to higher non-ionized fraction of the drug and lipophylicity, all this resulting in a second absorption peak, usually higher than the first one. I have often seen such kind of profiles with depot complex such as for exemple procaine-penicilline , but not in cases as the current so that I am not sure that my hypothesis can be correct. I would appreciate your opinion about this.


2017-02-03 10:46

@ helena colom
Posting: # 17004
Views: 562

 Double peak in hydroxychloroquine plasma curves

Hi to the south!

Nice recent overview on the double-peak phenomenon


Kindest regards, nobody
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum | Admin contact
16,926 Posts in 3,627 Threads, 1,029 registered users;
17 users online (0 registered, 17 guests).

EMEA. The European Medicines Evaluation Agency.
The drug regulatory agency of the European Union.
A statistician-free zone.    Stephen Senn

BEBAC Ing. Helmut Schütz